{
  "id": "clinical#screening_cues_8551539b",
  "content": "in two or more of the following:\n• impaired control over substance use (i.e. onset, frequency, intensity, duration, termination,\ncontext);\n• increasing precedence of substance use over other aspects of life, including maintenance\nof health, and daily activities and responsibilities, such that substance use continues\nor escalates despite the occurrence of harm or negative consequences (e.g. repeated\nrelationship disruption, occupational or scholastic consequences, negative impact on\nhealth);\n• physiological features indicative of neuroadaptation to the substance, including\ntolerance to the effects of the substance or a need to use increasing amounts\nof the substance to achieve the same effect; withdrawal symptoms following\ncessation or reduction in use of that substance; or repeated use of the substance or\nDiagnostic requirements for disorders due to substance use | Substance dependence\n464 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\npharmacologically similar substances to prevent or alleviate withdrawal symptoms\n(substance-specific features of withdrawal are described in Table 6.16, p. 484).\nNote: physiological features are only applicable for certain substances.\n• The features of dependence are usually evident over a period of at least 12 months, but the",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "relationships",
      "screening_cues",
      "referral"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues in two or more of the following:\n• impaired control over substance use (i.e. onset, frequency, intensity, duration, termination,\ncontext);\n• increasing precedence of substance use over other aspects of life, including maintenance\nof health, and daily activities and responsibilities, such that substance use continues\nor escalates despite the occurrence of harm or negative consequences (e.g. repeated\nrelationship disruption, occupational or scholastic consequences, negative impact on\nhealth);\n• physiological features indicative of neuroadaptation to the substance, including\ntolerance to the effects of the substance or a need to use increasing amounts\nof the substance to achieve the same effect; withdrawal symptoms following\ncessation or reduction in use of that substance; or repeated use of the substance or\nDiagnostic requirements for disorders due to substance use | Substance dependence\n464 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\npharmacologically similar substances to prevent or alleviate withdrawal symptoms\n(substance-specific features of withdrawal are described in Table 6.16, p. 484).\nNote: physiological features are only applicable for certain substances.\n• The features of dependence are usually evident over a period of at least 12 months, but the In two or more of the following:\n• impaired control over substance use (i.e. onset, frequency, intensity, duration, termination,\ncontext);\n• increasing precedence of substance use over other aspects of life, including ma..."
}